| 146 | 0 | 178 |
| 下载次数 | 被引频次 | 阅读次数 |
本综述系统论述了α疱疹病毒US4基因编码的糖蛋白gG的特点及其在病毒感染、毒力、神经侵袭、趋化因子结合与天然免疫调控中的功能，分析了gG在调节趋化因子活性、影响神经信号传导等方面的机制及其在疫苗研发和诊断中的应用潜力，为进一步探索人类和动物α疱疹病毒US4基因的功能及其防控策略提供一定参考。
Abstract：This review systematically examines the characteristics of glycoprotein gG encoded by the US4 geneof alphaherpesviruses and its roles in viral infection, virulence, neuroinvasion, chemokine binding, and innateimmune regulation. The mechanism by which gG modulates chemokine activity and influences neural signaltransduction, as well as its potential applications in vaccine development and diagnostics, are analyzed. Thisreview provides a reference for further investigations into the function of the US4 gene in human and animalalphaherpesviruses and its implications for prevention and control strategies.
[1] Gatherer D, Depledge DP, Hartley CA, et al. ICTV virus taxonomy profile:Herpesviridae 2021[J]. J Gen Virol, 2021, 102(10):001673. DOI:10. 1099/jgv. 0. 001673.
[2] Sucharita S, Krishnagopal A, van Drunen Littel-van den Hurk S. Comprehensive analysis of the tegument proteins involved in capsid transport and virion morphogenesis of alpha, beta and gamma herpesviruses[J]. Viruses, 2023, 15(10):2058. DOI:10. 3390/v15102058.
[3] Connolly SA, Jardetzky TS, Longnecker R. The structural basis of herpesvirus entry[J]. Nat Rev Microbiol, 2021, 19(2):110-121. DOI:10. 1038/s41579-020-00448-w.
[4] Helferich D, Veits J, Teifke JP, et al. The UL47 gene of avian infectious laryngotracheitis virus is not essential for in vitro replication but is relevant for virulence in chickens[J]. J Gen Virol, 2007, 88(Pt 3):732-742.DOI:10. 1099/vir. 0. 82533-0.
[5] Costes B, Ruiz-Argüello MB, Bryant NA, et al. Both soluble and membrane-anchored forms of Felid herpesvirus 1 glycoprotein G function as a broadspectrum chemokine-binding protein[J]. J Gen Virol,2005, 86(Pt 12):3209-3214. DOI:10. 1099/vir. 0. 81388-0.
[6] Viejo-Borbolla A, Mu?oz A, Tabarés E, et al.Glycoprotein G from pseudorabies virus binds to chemokines with high affinity and inhibits their function[J]. J Gen Virol, 2010, 91(Pt 1):23-31. DOI:10. 1099/vir. 0. 011940-0.
[7] Bryant NA, Davis-Poynter N, Vanderplasschen A, et al. Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins[J]. EMBO J, 2003, 22(4):833-846. DOI:10. 1093/emboj/cdg092.
[8] Kropp KA, Srivaratharajan S, Ritter B, et al.Identification of the cleavage domain within glycoprotein G of herpes simplex virus type 2[J]. Viruses, 2020, 12(12):1428. DOI:10. 3390/v12121428.
[9] Drummer HE, Studdert MJ, Crabb BS. Equine herpesvirus-4 glycoprotein G is secreted as a disulphidelinked homodimer and is present as two homodimeric species in the virion[J]. J Gen Virol, 1998, 79(Pt 5):1205-1213. DOI:10. 1099/0022-1317-79-5-1205.
[10]Losinno A, Vissani MA, Sanchez D, et al. Equid herpesvirus type 3 infection produces membraneassociated and secreted forms of glycoprotein G that are not required for efficient cell-to-cell spread of the virus in vitro[J]. Arch Virol, 2023, 168(4):122. DOI:10. 1007/s00705-023-05727-4.
[11]Helferich D, Veits J, Mettenleiter TC, et al.Identification of transcripts and protein products of the UL31 UL37 UL46 UL47 UL48 UL49 and US4 gene homologues of avian infectious laryngotracheitis virus[J]. J Gen Virol, 2007, 88(Pt 3):719-731. DOI:10. 1099/vir. 0. 82532-0.
[12]Ackermann M, Longnecker R, Roizman B, et al.Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1[J].Virology, 1986, 150(1):207-220. DOI:10. 1016/0042-6822(86)90280-1.
[13]Viejo-Borbolla A, Martinez-Martín N, Nel HJ, et al.Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses[J]. PLoS Pathog, 2012, 8(2):e1002497. DOI:10. 1371/journal. ppat. 1002497.
[14]Bennett LM, Timmins JG, Thomsen DR, et al. The processing of pseudorabies virus glycoprotein gX in infected cells and in an uninfected cell line[J]. Virology,1986, 155(2):707-715. DOI:10. 1016/0042-6822(86)90230-8.
[15]Keil GM, Engelhardt T, Karger A, et al. Bovine herpesvirus 1 U(s)open reading frame 4 encodes a glycoproteoglycan[J]. J Virol, 1996, 70(5):3032-3038. DOI:10. 1128/JVI. 70. 5. 3032-3038. 1996.
[16]Engelhardt T, Keil GM. Identification and characterization of the bovine herpesvirus 5 US4 gene and gene products[J]. Virology, 1996, 225(1):126-135. DOI:10. 1006/viro. 1996. 0580.
[17]Baker L, Chitas AML, Hartley CA, et al.Recombinant herpesvirus glycoprotein G improves the protective immune response to Helicobacter pylori vaccination in a mouse model of disease[J]. PLoS One,2014, 9(5):e96563. DOI:10. 1371/journal.pone. 0096563.
[18]Crabb BS, Nagesha HS, Studdert MJ. Identification of equine herpesvirus 4 glycoprotein G:a type-specific,secreted glycoprotein[J]. Virology, 1992, 190(1):143-154. DOI:10. 1016/0042-6822(92)91200-e.
[19]Costes B, Thirion M, Dewals B, et al. Felid herpesvirus 1 glycoprotein G is a structural protein that mediates the binding of chemokines on the viral envelope[J]. Microbes Infect, 2006, 8(11):2657-2667. DOI:10. 1016/j. micinf. 2006. 07. 014.
[20]Devlin JM, Viejo-Borbolla A, Browning GF, et al.Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus[J]. Vaccine, 2010, 28(5):1325-1332. DOI:10. 1016/j. vaccine. 2009. 11. 013.
[21]von Einem J, Smith PM, Van de Walle GR, et al. In vitro and in vivo characterization of equine herpesvirus type 1(EHV-1)mutants devoid of the viral chemokinebinding glycoprotein G(gG)[J]. Virology, 2007, 362(1):151-162. DOI:10. 1016/j. virol. 2006. 12. 008.
[22]Thormann N, Van de Walle GR, Azab W, et al. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4(EHV-1 and EHV-4)in immune modulation and virulence[J]. Virus Res, 2012, 169(1):203-211. DOI:10. 1016/j. virusres. 2012. 07. 029.
[23]Adamiak B, Ekblad M, Bergstr?m T, et al. Herpes simplex virus type 2 glycoprotein G is targeted by the sulfated oligo-and polysaccharide inhibitors of virus attachment to cells[J]. J Virol, 2007, 81(24):13424-13434. DOI:10. 1128/JVI. 01528-07.
[24]Demmin GL, Clase AC, Randall JA, et al. Insertions in the gG gene of pseudorabies virus reduce expression of the upstream Us3 protein and inhibit cell-to-cell spread of virus infection[J]. J Virol, 2001, 75(22):10856-10869. DOI:10. 1128/JVI. 75. 22. 10856-10869. 2001.
[25]Mahmoudian A, Markham PF, Noormohammadi AH,et al. Differential transcription patterns in wild-type and glycoprotein G-deleted infectious laryngotracheitis viruses[J]. Avian Pathol, 2013, 42(3):253-259.DOI:10. 1080/03079457. 2013. 780649.
[26]Sun Z, Zhang M. Effect of the infectious laryngotracheitis virus(ILTV)glycoprotein G on virus attachment, penetration, growth curve and direct cell-tocell spread[J]. Sci China Ser C Life Sci, 2005, 48(5):487-494. DOI:10. 1360/062005-17.
[27]Komala Sari T, Pritchard SM, Cunha CW, et al.Contributions of herpes simplex virus 1 envelope proteins to entry by endocytosis[J]. J Virol, 2013, 87(24):13922-13926. DOI:10. 1128/JVI. 02500-13.
[28]Tran LC, Kissner JM, Westerman LE, et al. A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo[J]. Proc Natl Acad Sci USA, 2000, 97(4):1818-1822. DOI:10. 1073/pnas. 020510297.
[29]Nakamichi K, Ohara K, Kuroki D, et al. Bovine herpesvirus 1 glycoprotein G is required for viral growth by cell-to-cell infection[J]. Virus Res, 2000, 68(2):175-181. DOI:10. 1016/s0168-1702(00)00171-4.
[30]Nakamichi K, Matsumoto Y, Otsuka H. Bovine herpesvirus 1 glycoprotein G is necessary for maintaining cell-to-cell junctional adherence among infected cells[J].Virology, 2002, 294(1):22-30. DOI:10. 1006/viro. 2001. 1264.
[31]Nakamichi K, Kuroki D, Matsumoto Y, et al. Bovine herpesvirus 1 glycoprotein G is required for prevention of apoptosis and efficient viral growth in rabbit kidney cells[J]. Virology, 2001, 279(2):488-498. DOI:10. 1006/viro. 2000. 0740.
[32]Pontejo SM, Murphy PM. Chemokines encoded by herpesviruses[J]. J Leukoc Biol, 2017, 102(5):1199-1217. DOI:10. 1189/jlb. 4RU0417-145RR.
[33]Schlecht-Louf G, Federici S, Ryffel B, et al. Editorial:The chemokine system in epithelial immunity[J]. Front Immunol, 2024, 15:1481686. DOI:10. 3389/fimmu. 2024. 1481686.
[34]Crijns H, Vanheule V, Proost P. Targeting chemokineglycosaminoglycan interactions to inhibit inflammation[J]. Front Immunol, 2020, 11:483. DOI:10. 3389/fimmu. 2020. 00483.
[35]Van de Walle GR, Kaufer BB, Chbab N, et al.Analysis of the herpesvirus chemokine-binding glycoprotein G residues essential for chemokine binding and biological activity[J]. J Biol Chem, 2009, 284(9):5968-5976. DOI:10. 1074/jbc. M808127200.
[36]Van de Walle GR, May ML, Sukhumavasi W, et al.Herpesvirus chemokine-binding glycoprotein G(gG)efficiently inhibits neutrophil chemotaxis in vitro and in vivo[J]. J Immunol, 2007, 179(6):4161-4169. DOI:10. 4049/jimmunol. 179. 6. 4161.
[37]González-Motos V, Kropp KA, Viejo-Borbolla A.Chemokine binding proteins:an immunomodulatory strategy going viral[J]. Cytokine Growth Factor Rev,2016, 30:71-80. DOI:10. 1016/j.cytogfr. 2016. 02. 007.
[38]Martínez-Martín N, Viejo-Borbolla A, Alcami A.Herpes simplex virus particles interact with chemokines and enhance cell migration[J]. J Gen Virol, 2016, 97(11):3007-3016. DOI:10. 1099/jgv. 0. 000616.
[39]Martinez-Martin N, Viejo-Borbolla A, Martín R, et al.Herpes simplex virus enhances chemokine function through modulation of receptor trafficking and oligomerization[J]. Nat Commun, 2015, 6:6163.DOI:10. 1038/ncomms7163.
[40]Bendezu J, Morales Ruiz S, Montesinos R, et al.Glycoprotein G(gG)production profile during infectious laryngotracheitis virus(ILTV)infection[J]. PLoS One, 2019, 14(8):e0219475. DOI:10. 1371/journal.pone. 0219475.
[41]Devlin JM, Browning GF, Hartley CA, et al.Glycoprotein G is a virulence factor in infectious laryngotracheitis virus[J]. J Gen Virol, 2006, 87(Pt10):2839-2847. DOI:10. 1099/vir. 0. 82194-0.
[42]Coppo MJC, Devlin JM, Legione AR, et al. Infectious laryngotracheitis virus viral chemokine-binding protein glycoprotein G alters transcription of key inflammatory mediators in vitro and in vivo[J]. J Virol, 2017, 92(1):e01534-17. DOI:10. 1128/JVI. 01534-17.
[43]Sun G, Kropp KA, Kirchner M, et al. Herpes simplex virus type 1 modifies the protein composition of extracellular vesicles to promote neurite outgrowth and neuroinfection[J]. mBio, 2024, 15(2):e0330823.DOI:10. 1128/mbio. 03308-23.
[44]Balachandran N, Hutt-Fletcher LM. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2[J]. J Virol, 1985, 54(3):825-832. DOI:10. 1128/JVI. 54. 3. 825-832. 1985.
[45]Kropp KA, López-Mu?oz AD, Ritter B, et al. Herpes simplex virus 2 counteracts neurite outgrowth repulsion during infection in a nerve growth factor-dependent manner[J]. J Virol, 2020, 94(20):e01370-20. DOI:10. 1128/JVI. 01370-20.
[46]Cabrera JR, Viejo-Borbolla A, Martinez-Martín N, et al. Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection[J]. PLoS Pathog, 2015,11(1):e1004571. DOI:10. 1371/journal.ppat. 1004571.
[47]Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system:a migration from immunology to neurobiology[J]. Prog Neurobiol,2008, 84(2):116-131. DOI:10. 1016/j.pneurobio. 2007. 11. 003.
[48]Su B, Pan S, He X, et al. Sprouting of nervous fibers and upregulation of C-X-C chemokine receptor type 4expression in hippocampal formation of rats with enhanced spatial learning and memory[J]. Anat Rec(Hoboken), 2012, 295(1):121-126. DOI:10. 1002/ar. 21518.
[49]Weihrauch T, Limberg MM, Gray N, et al.Neurotrophins:neuroimmune interactions in human atopic diseases[J]. Int J Mol Sci, 2023, 24(7):6105.DOI:10. 3390/ijms24076105.
[50]Reis C, Chambel S, Ferreira A, et al. Involvement of nerve growth factor(NGF)in chronic neuropathic paina systematic review[J]. Rev Neurosci, 2022, 34(1):75-84. DOI:10. 1515/revneuro-2022-0037.
[51]Zhang M, Fu S, Deng M, et al. Attenuation of bovine herpesvirus type 1 by deletion of its glycoprotein G and tk genes and protection against virulent viral challenge[J]. Vaccine, 2011, 29(48):8943-8950. DOI:10. 1016/j. vaccine. 2011. 09. 050.
[52]Cao C, An R, Yu Y, et al. BICP0 negatively regulates TRAF6-mediated NF-κB and interferon activation by promoting K48-linked polyubiquitination of TRAF6[J].Front Microbiol, 2020, 10:3040. DOI:10. 3389/fmicb. 2019. 03040.
[53]Matundan HH, Jaggi U, Ghiasi H. Herpes simplex virus 1 glycoproteins differentially regulate the activity of costimulatory molecules and T cells[J]. mSphere,2022, 7(5):e0038222. DOI:10. 1128/msphere. 00382-22.
[54]相生瑞，陈柳，霍苏馨，等.鸭瘟病毒gG基因缺失株的构建及其免疫保护效果研究[J].中国预防兽医学报，2024, 46(09):946-53.
[55]Sabir AJ, Adams TE, O’ Rourke D, et al.Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus(ILTV)and protective immunity[J]. Vet Microbiol, 2019, 228:252-258. DOI:10. 1016/j. vetmic. 2018. 12. 010.
[56]Pavulraj S, Stout RW, Paulsen DB, et al. A quadruple gene-deleted live BoHV-1 subunit RVFV vaccine vector reactivates from latency and replicates in the TG neurons of calves but is not transported to and shed from nasal mucosa[J]. Viruses, 2024, 16(9):1497. DOI:10. 3390/v16091497.
[57]Zhang S, Liu G, Zhang Y, et al. Investigation of the safety and protective efficacy of an attenuated and marker M. bovis-BoHV-1 combined vaccine in bovines[J].Front Immunol, 2024, 15:1367253. DOI:10. 3389/fimmu. 2024. 1367253.
[58]Pavulraj S, Stout RW, Barras ED, et al. A novel quadruple gene-deleted BoHV-1-vectored RVFV subunit vaccine induces humoral and cell-mediated immune response against rift valley fever in calves[J].Viruses, 2023, 15(11):2183. DOI:10. 3390/v15112183.
[59]Marawan MA, Deng M, Wang C, et al.Characterization of BoHV-1 gG-/tk-/GE-Mutant in Differential Protein Expression, Virulence, and Immunity[J]. Vet Sci, 2021, 8(11):253. DOI:10. 3390/vetsci8110253.
[60]Atasoy MO, Rohaim MA, Munir M. Simultaneous deletion of virulence factors and insertion of antigens into the infectious laryngotracheitis virus using NHEJCRISPR/Cas9 and cre-lox system for construction of a stable vaccine vector[J]. Vaccines(Basel), 2019, 7(4):207. DOI:10. 3390/vaccines7040207.
[61]Wolfrum N. Infectious laryngotracheitis:an update on current approaches for prevention of an old disease[J]. J Anim Sci, 2020, 98(Suppl 1):S27-S35. DOI:10. 1093/jas/skaa133.
[62]Stanfield BA, Bravo FJ, Dixon DA, et al. Cross protective efficacy of the Non-Neurotropic live attenuated herpes simplex virus type 1 vaccine VC-2 is enhanced by intradermal vaccination and deletion of glycoprotein G[J]. Vaccine, 2022, 40(42):6093-6099. DOI:10. 1016/j. vaccine. 2022. 09. 015.
[63]Korsa MG, Devlin JM, Hartley CA, et al.Determination of the minimum protective dose of a glycoprotein-G-deficient infectious laryngotracheitis virus vaccine delivered via eye-drop to week-old chickens[J].PLoS One, 2018, 13(12):e0207611. DOI:10. 1371/journal. pone. 0207611.
[64]Zhang S, Zhang Y, Liu G, et al. The safety and protective efficacy evaluation of an attenuated M. bovisBoHV-1 bivalent vaccine in rabbits[J]. Vaccines(Basel), 2023, 11(11):1698. DOI:10. 3390/vaccines11111698.
[65]Zhang S, Liu G, Wu W, et al. Investigation of the optimal immunization dose and protective efficacy of an attenuated and marker M. bovis-bovine herpesvirus type1 combined vaccine in rabbits[J]. Animals(Basel),2024, 14(5):748. DOI:10. 3390/ani14050748.
[66]Sch?dler J, Sigrist B, Meier SM, et al. Virus-like particles in a new vaccination approach against infectious laryngotracheitis[J]. J Gen Virol, 2019, 100(6):1013-1026. DOI:10. 1099/jgv. 0. 001272.
[67]Liu T, Liu JF, Yu H, et al. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential[J]. Singapore Med J, 2015, 56(6):346-352. DOI:10. 11622/smedj. 2014197.
[68]Risinger C, S?rensen KK, Jensen KJ, et al. Linear multiepitope(glyco)peptides for type-specific serology of herpes simplex virus(HSV)infections[J]. ACS Infect Dis, 2017, 3(5):360-367. DOI:10. 1021/acsinfecdis. 7b00001.
[69]Jun W, Hu R, Hyland L, et al. Expression and characterization of the soluble form of recombinant mature HSV-2 glycoprotein G for use in anti-HSV-2IgG serodiagnostic immunoassay[J]. J Virol Meth,2018, 252:65-69. DOI:10. 1016/j.jviromet. 2017. 10. 021.
[70]Shil NK, Legione AR, Markham PF, et al.Development and validation of TaqMan real-time polymerase chain reaction assays for the quantitative and differential detection of wild-type infectious laryngotracheitis viruses from a glycoprotein G-deficient candidate vaccine strain[J]. Avian Dis, 2015, 59(1):7-13. DOI:10. 1637/10810-030414-reg. 1.
[71]de Ory F, Guisasola ME, Balfagón P, et al.Comparison of commercial methods of immunoblot,ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and-2IgG[J]. J Clin Lab Anal, 2018, 32(1):e22203. DOI:10. 1002/jcla. 22203.
[72]Oberto F, Carella E, Caruso C, et al. A qualitative PCR assay for the discrimination of bubaline herpesvirus1, bovine herpesvirus 1 and bovine herpesvirus 5[J].Microorganisms, 2023, 11(3):577. DOI:10. 3390/microorganisms11030577.
[73]Hernaez B, AlcamíA. Virus-encoded cytokine and chemokine decoy receptors[J]. Curr Opin Immunol,2020, 66:50-56. DOI:10. 1016/j. coi. 2020. 04. 008.
[74]Gopakumar G, Diaz-Méndez A, Coppo MJC, et al.Transcriptomic analyses of host-virus interactions during in vitro infection with wild-type and glycoprotein gdeficient（ΔgG） strains of ILTV in primary and continuous cell cultures[J]. PLoS One, 2024, 19(10):e0311874. DOI:10. 1371/journal. pone. 0311874.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.240294
中图分类号:Q939.4
引用信息:
[1]邱洁,汪铭书,程安春.α疱疹病毒US4基因及其编码蛋白gG的研究进展[J].病毒学报,2025,41(03):956-964.DOI:10.13242/j.cnki.bingduxuebao.240294.
基金信息:
财政部和农业农村部国家现代农业产业技术体系专项（项目号：CARS-42-17）,题目：免疫抑制病防控~~
2024-12-04
2024
2025-01-20
2025-04-17
2025
1
2025-04-18
2025-04-18
2025-04-18